Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2005-08-05

AUTHORS

S A Kaliberov, S Chiz, L N Kaliberova, V Krendelchtchikova, D Della Manna, T Zhou, D J Buchsbaum

ABSTRACT

Combined treatment using adenoviral-directed enzyme/prodrug therapy and immunotherapy has the potential to become a powerful alternative method of cancer therapy. We have developed adenoviral vectors encoding the cytosine deaminase gene (Ad-CD) and cytosine deaminase:uracil phosphoribosyltransferase fusion gene (Ad-CD:UPRT). A monoclonal antibody, TRA-8, specifically binds to death receptor 5, one of two death receptors bound by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). The purpose of this study was to evaluate cytotoxicity in vitro and therapeutic efficacy in vivo of the combination of Ad-CD:UPRT and TRA-8 against human pancreatic cancer and glioma cell lines. The present study demonstrates that Ad-CD:UPRT infection resulted in increased 5-FC-mediated cell killing, compared with Ad-CD. Furthermore, a significant increase of cytotoxicity following Ad-CD:UPRT/5-FC and TRA-8 treatment of cancer cells in vitro was demonstrated. Animal studies showed significant inhibition of tumor growth of MIA PaCa-2 pancreatic and D54MG glioma xenografts by the combination of Ad-CD:UPRT/5-FC plus TRA-8 as compared with either agent alone or no treatment. The results suggest that the combination of Ad-CD:UPRT/5-FC with TRA-8 produces an additive cytotoxic effect in cancer cells in vitro and in vivo. These data indicate that combined treatment with enzyme/prodrug therapy and TRAIL immunotherapy provides a promising approach for cancer therapy. More... »

PAGES

203-214

References to SciGraph publications

  • 2004-01. Apoptosis Induction With 5-Fluorocytosine/Cytosine Deaminase gene Therapy for Human Malignant Glioma Cells Mediated by Adenovirus in JOURNAL OF NEURO-ONCOLOGY
  • 2001-08-01. Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity in NATURE MEDICINE
  • 2004-09-27. Multidomain Bcl-2 homolog Bax but not Bak mediates synergistic induction of apoptosis by TRAIL and 5-FU through the mitochondrial apoptosis pathway in ONCOGENE
  • 2004-02-19. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells in GENE THERAPY
  • 2002-04-15. Current Progress in Suicide Gene Therapy for Cancer in WORLD JOURNAL OF SURGERY
  • 2000-04-01. Expression of Escherichia coli uracil phosphoribosyltransferase gene in murine colon carcinoma cells augments the antitumoral effect of 5-fluorouracil and induces protective immunity in CANCER GENE THERAPY
  • 2000-06-01. Fractionated radiation therapy in combination with adenoviral delivery of the cytosine deaminase gene and 5-fluorocytosine enhances cytotoxic and antitumor effects in human colorectal and cholangiocarcinoma models in GENE THERAPY
  • 2001-10-01. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase in GENE THERAPY
  • 2003-04-03. Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway in ONCOGENE
  • 2000-07-01. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of Escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine in CANCER GENE THERAPY
  • 2002-09-11. Combined radiation and gene therapy for brain tumors with adenovirus-mediated transfer of cytosine deaminase and uracil phosphoribosyltransferase genes in CANCER GENE THERAPY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/sj.cgt.7700874

    DOI

    http://dx.doi.org/10.1038/sj.cgt.7700874

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1048858643

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/16082379


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adenoviridae", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Analysis of Variance", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Monoclonal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Blotting, Western", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cytosine Deaminase", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cytotoxicity Tests, Immunologic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Flow Cytometry", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Genes, Transgenic, Suicide", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Genetic Therapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glioma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunotherapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice, Nude", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Microscopy, Fluorescence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pancreatic Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pentosyltransferases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prodrugs", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, TNF-Related Apoptosis-Inducing Ligand", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, Tumor Necrosis Factor", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Radiation Oncology, University of Alabama at Birmingham, 674 Wallace Tumor Institute, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Department of Radiation Oncology, University of Alabama at Birmingham, 674 Wallace Tumor Institute, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kaliberov", 
            "givenName": "S A", 
            "id": "sg:person.01206020250.68", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206020250.68"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Radiation Oncology, University of Alabama at Birmingham, 674 Wallace Tumor Institute, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Department of Radiation Oncology, University of Alabama at Birmingham, 674 Wallace Tumor Institute, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chiz", 
            "givenName": "S", 
            "id": "sg:person.01042766474.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042766474.08"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Radiation Oncology, University of Alabama at Birmingham, 674 Wallace Tumor Institute, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Department of Radiation Oncology, University of Alabama at Birmingham, 674 Wallace Tumor Institute, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kaliberova", 
            "givenName": "L N", 
            "id": "sg:person.01051663455.47", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051663455.47"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Radiation Oncology, University of Alabama at Birmingham, 674 Wallace Tumor Institute, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Department of Radiation Oncology, University of Alabama at Birmingham, 674 Wallace Tumor Institute, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Krendelchtchikova", 
            "givenName": "V", 
            "id": "sg:person.01302340455.26", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302340455.26"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Radiation Oncology, University of Alabama at Birmingham, 674 Wallace Tumor Institute, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Department of Radiation Oncology, University of Alabama at Birmingham, 674 Wallace Tumor Institute, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Della Manna", 
            "givenName": "D", 
            "id": "sg:person.014171430277.88", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014171430277.88"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, University of Alabama at Birmingham, 674 Wallace Tumor Institute, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Department of Medicine, University of Alabama at Birmingham, 674 Wallace Tumor Institute, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Zhou", 
            "givenName": "T", 
            "id": "sg:person.0664616100.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664616100.38"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Radiation Oncology, University of Alabama at Birmingham, 674 Wallace Tumor Institute, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Department of Radiation Oncology, University of Alabama at Birmingham, 674 Wallace Tumor Institute, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Buchsbaum", 
            "givenName": "D J", 
            "id": "sg:person.01137705050.57", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137705050.57"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/sj.cgt.7700506", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037799653", 
              "https://doi.org/10.1038/sj.cgt.7700506"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1206290", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047996205", 
              "https://doi.org/10.1038/sj.onc.1206290"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.cgt.7700154", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003917459", 
              "https://doi.org/10.1038/sj.cgt.7700154"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00268-002-4053-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001468017", 
              "https://doi.org/10.1007/s00268-002-4053-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.gt.3301557", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036158702", 
              "https://doi.org/10.1038/sj.gt.3301557"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1207971", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033400756", 
              "https://doi.org/10.1038/sj.onc.1207971"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.cgt.7700189", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007196669", 
              "https://doi.org/10.1038/sj.cgt.7700189"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.gt.3301196", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019345486", 
              "https://doi.org/10.1038/sj.gt.3301196"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.gt.3302215", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013484231", 
              "https://doi.org/10.1038/sj.gt.3302215"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/91000", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047281881", 
              "https://doi.org/10.1038/91000"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/b:neon.0000013494.98345.80", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036496053", 
              "https://doi.org/10.1023/b:neon.0000013494.98345.80"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2005-08-05", 
        "datePublishedReg": "2005-08-05", 
        "description": "Combined treatment using adenoviral-directed enzyme/prodrug therapy and immunotherapy has the potential to become a powerful alternative method of cancer therapy. We have developed adenoviral vectors encoding the cytosine deaminase gene (Ad-CD) and cytosine deaminase:uracil phosphoribosyltransferase fusion gene (Ad-CD:UPRT). A monoclonal antibody, TRA-8, specifically binds to death receptor 5, one of two death receptors bound by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). The purpose of this study was to evaluate cytotoxicity in vitro and therapeutic efficacy in vivo of the combination of Ad-CD:UPRT and TRA-8 against human pancreatic cancer and glioma cell lines. The present study demonstrates that Ad-CD:UPRT infection resulted in increased 5-FC-mediated cell killing, compared with Ad-CD. Furthermore, a significant increase of cytotoxicity following Ad-CD:UPRT/5-FC and TRA-8 treatment of cancer cells in vitro was demonstrated. Animal studies showed significant inhibition of tumor growth of MIA PaCa-2 pancreatic and D54MG glioma xenografts by the combination of Ad-CD:UPRT/5-FC plus TRA-8 as compared with either agent alone or no treatment. The results suggest that the combination of Ad-CD:UPRT/5-FC with TRA-8 produces an additive cytotoxic effect in cancer cells in vitro and in vivo. These data indicate that combined treatment with enzyme/prodrug therapy and TRAIL immunotherapy provides a promising approach for cancer therapy.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/sj.cgt.7700874", 
        "inLanguage": "en", 
        "isAccessibleForFree": false, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2440190", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1112008", 
            "issn": [
              "0929-1903", 
              "1476-5500"
            ], 
            "name": "Cancer Gene Therapy", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "2", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "13"
          }
        ], 
        "keywords": [
          "enzyme/prodrug therapy", 
          "tumor necrosis factor-related apoptosis-inducing ligand", 
          "TRA-8", 
          "prodrug therapy", 
          "cancer cells", 
          "human pancreatic cancer", 
          "cancer therapy", 
          "necrosis factor-related apoptosis-inducing ligand", 
          "factor-related apoptosis-inducing ligand", 
          "TRA-8 treatment", 
          "additive cytotoxic effect", 
          "cytosine deaminase gene", 
          "death receptor 5", 
          "MIA PaCa-2", 
          "glioma cell lines", 
          "apoptosis-inducing ligand", 
          "suicide gene expression", 
          "antibody treatment", 
          "pancreatic cancer", 
          "cancer cell cytotoxicity", 
          "glioma xenografts", 
          "receptor 5", 
          "animal studies", 
          "therapeutic efficacy", 
          "tumor growth", 
          "cell cytotoxicity", 
          "Combined treatment", 
          "therapy", 
          "PaCa-2", 
          "monoclonal antibodies", 
          "significant inhibition", 
          "adenoviral vector", 
          "cytotoxic effects", 
          "immunotherapy", 
          "treatment", 
          "significant increase", 
          "cell lines", 
          "cell killing", 
          "death receptors", 
          "fusion gene", 
          "cytosine deaminase", 
          "vitro", 
          "present study", 
          "cytotoxicity", 
          "vivo", 
          "gene expression", 
          "cells", 
          "deaminase gene", 
          "xenografts", 
          "cancer", 
          "infection", 
          "antibodies", 
          "receptors", 
          "study", 
          "efficacy", 
          "UPRT", 
          "inhibition", 
          "genes", 
          "killing", 
          "combination", 
          "promising approach", 
          "expression", 
          "agents", 
          "deaminase", 
          "alternative method", 
          "increase", 
          "effect", 
          "purpose", 
          "data", 
          "lines", 
          "powerful alternative method", 
          "potential", 
          "ligands", 
          "results", 
          "growth", 
          "method", 
          "approach", 
          "vector"
        ], 
        "name": "Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity", 
        "pagination": "203-214", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1048858643"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/sj.cgt.7700874"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "16082379"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/sj.cgt.7700874", 
          "https://app.dimensions.ai/details/publication/pub.1048858643"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-05-10T09:53", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_411.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/sj.cgt.7700874"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700874'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700874'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700874'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700874'


     

    This table displays all metadata directly associated to this object as RDF triples.

    322 TRIPLES      22 PREDICATES      138 URIs      119 LITERALS      30 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/sj.cgt.7700874 schema:about N153de9a9627d448a8e26798ded3b953a
    2 N288065482cd14457abe040c5267cdd85
    3 N3114eeb16e6945b6beda0f7019afaa2f
    4 N3c49331df49449f4a21927f765f04bd6
    5 N3f2521dce4cc49f493931e340d82e813
    6 N488b3bacf3ff466fbc05bddb69e3ea1f
    7 N4a8462ebd01a47ccb7bd93303738f439
    8 N4f2e0582cd0a4623828d955af8374898
    9 N5771bbeaa7ad42779934b3bdbfe1c407
    10 N57923accccbb4bd08bcae279522e7d15
    11 N60948e3cdf6d424389e0cdbe91052544
    12 N65a1d4292984480f9737d8b4c67238a1
    13 N6b7e8ce5406f4b2097c09cf3075ec5ea
    14 N720f9e44e8a74d0f831b04338cb7e857
    15 N7bcd38b0d57843959711941d741c9444
    16 N9cd02f0b795248df86325657a9e3d445
    17 Nab36a794517d4d62a1e0179dcacffacd
    18 Nafdbfbb9f11940c2b45ddddb57f2889c
    19 Nb87520f3735849018a3fc977d533a849
    20 Nd300d20f10d2401cb7dbb94b0b1b0b8b
    21 Ne1b725aa86a447dba98e8f7e2d5b3731
    22 Ne7159184d4ac4df4b2995a6a40a08539
    23 Ne96165955aec4624b850375a0209d5ac
    24 anzsrc-for:11
    25 anzsrc-for:1112
    26 schema:author N48d8ce970c9746a2b6fead7f006b8fce
    27 schema:citation sg:pub.10.1007/s00268-002-4053-5
    28 sg:pub.10.1023/b:neon.0000013494.98345.80
    29 sg:pub.10.1038/91000
    30 sg:pub.10.1038/sj.cgt.7700154
    31 sg:pub.10.1038/sj.cgt.7700189
    32 sg:pub.10.1038/sj.cgt.7700506
    33 sg:pub.10.1038/sj.gt.3301196
    34 sg:pub.10.1038/sj.gt.3301557
    35 sg:pub.10.1038/sj.gt.3302215
    36 sg:pub.10.1038/sj.onc.1206290
    37 sg:pub.10.1038/sj.onc.1207971
    38 schema:datePublished 2005-08-05
    39 schema:datePublishedReg 2005-08-05
    40 schema:description Combined treatment using adenoviral-directed enzyme/prodrug therapy and immunotherapy has the potential to become a powerful alternative method of cancer therapy. We have developed adenoviral vectors encoding the cytosine deaminase gene (Ad-CD) and cytosine deaminase:uracil phosphoribosyltransferase fusion gene (Ad-CD:UPRT). A monoclonal antibody, TRA-8, specifically binds to death receptor 5, one of two death receptors bound by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). The purpose of this study was to evaluate cytotoxicity in vitro and therapeutic efficacy in vivo of the combination of Ad-CD:UPRT and TRA-8 against human pancreatic cancer and glioma cell lines. The present study demonstrates that Ad-CD:UPRT infection resulted in increased 5-FC-mediated cell killing, compared with Ad-CD. Furthermore, a significant increase of cytotoxicity following Ad-CD:UPRT/5-FC and TRA-8 treatment of cancer cells in vitro was demonstrated. Animal studies showed significant inhibition of tumor growth of MIA PaCa-2 pancreatic and D54MG glioma xenografts by the combination of Ad-CD:UPRT/5-FC plus TRA-8 as compared with either agent alone or no treatment. The results suggest that the combination of Ad-CD:UPRT/5-FC with TRA-8 produces an additive cytotoxic effect in cancer cells in vitro and in vivo. These data indicate that combined treatment with enzyme/prodrug therapy and TRAIL immunotherapy provides a promising approach for cancer therapy.
    41 schema:genre article
    42 schema:inLanguage en
    43 schema:isAccessibleForFree false
    44 schema:isPartOf Nacdd708e8012432fb568486d8acece81
    45 Nf250e7f636524938a49bfc8f35e1cf07
    46 sg:journal.1112008
    47 schema:keywords Combined treatment
    48 MIA PaCa-2
    49 PaCa-2
    50 TRA-8
    51 TRA-8 treatment
    52 UPRT
    53 additive cytotoxic effect
    54 adenoviral vector
    55 agents
    56 alternative method
    57 animal studies
    58 antibodies
    59 antibody treatment
    60 apoptosis-inducing ligand
    61 approach
    62 cancer
    63 cancer cell cytotoxicity
    64 cancer cells
    65 cancer therapy
    66 cell cytotoxicity
    67 cell killing
    68 cell lines
    69 cells
    70 combination
    71 cytosine deaminase
    72 cytosine deaminase gene
    73 cytotoxic effects
    74 cytotoxicity
    75 data
    76 deaminase
    77 deaminase gene
    78 death receptor 5
    79 death receptors
    80 effect
    81 efficacy
    82 enzyme/prodrug therapy
    83 expression
    84 factor-related apoptosis-inducing ligand
    85 fusion gene
    86 gene expression
    87 genes
    88 glioma cell lines
    89 glioma xenografts
    90 growth
    91 human pancreatic cancer
    92 immunotherapy
    93 increase
    94 infection
    95 inhibition
    96 killing
    97 ligands
    98 lines
    99 method
    100 monoclonal antibodies
    101 necrosis factor-related apoptosis-inducing ligand
    102 pancreatic cancer
    103 potential
    104 powerful alternative method
    105 present study
    106 prodrug therapy
    107 promising approach
    108 purpose
    109 receptor 5
    110 receptors
    111 results
    112 significant increase
    113 significant inhibition
    114 study
    115 suicide gene expression
    116 therapeutic efficacy
    117 therapy
    118 treatment
    119 tumor growth
    120 tumor necrosis factor-related apoptosis-inducing ligand
    121 vector
    122 vitro
    123 vivo
    124 xenografts
    125 schema:name Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity
    126 schema:pagination 203-214
    127 schema:productId N2f358b78f0554dacb2467cc0f2e28e0b
    128 N5ced7d01b80f41caafb30b9f6e786514
    129 Nc69b18a49502479193360b5bc3b47840
    130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048858643
    131 https://doi.org/10.1038/sj.cgt.7700874
    132 schema:sdDatePublished 2022-05-10T09:53
    133 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    134 schema:sdPublisher Nf3f92fb86ecf400a9522488588b5855a
    135 schema:url https://doi.org/10.1038/sj.cgt.7700874
    136 sgo:license sg:explorer/license/
    137 sgo:sdDataset articles
    138 rdf:type schema:ScholarlyArticle
    139 N0b1c51784688480f99364fd087604772 rdf:first sg:person.01302340455.26
    140 rdf:rest N5d35babb4c4845cd8a14c58b748c9d40
    141 N153de9a9627d448a8e26798ded3b953a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Receptors, Tumor Necrosis Factor
    143 rdf:type schema:DefinedTerm
    144 N288065482cd14457abe040c5267cdd85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name Receptors, TNF-Related Apoptosis-Inducing Ligand
    146 rdf:type schema:DefinedTerm
    147 N2f358b78f0554dacb2467cc0f2e28e0b schema:name pubmed_id
    148 schema:value 16082379
    149 rdf:type schema:PropertyValue
    150 N3114eeb16e6945b6beda0f7019afaa2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    151 schema:name Prodrugs
    152 rdf:type schema:DefinedTerm
    153 N398127fd832d4d2fa49f5f0b2cd0e90a rdf:first sg:person.0664616100.38
    154 rdf:rest N71fe8e7d5355404e8a27e5869d74f774
    155 N3c49331df49449f4a21927f765f04bd6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    156 schema:name Adenoviridae
    157 rdf:type schema:DefinedTerm
    158 N3f2521dce4cc49f493931e340d82e813 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    159 schema:name Humans
    160 rdf:type schema:DefinedTerm
    161 N488b3bacf3ff466fbc05bddb69e3ea1f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    162 schema:name Genes, Transgenic, Suicide
    163 rdf:type schema:DefinedTerm
    164 N48d8ce970c9746a2b6fead7f006b8fce rdf:first sg:person.01206020250.68
    165 rdf:rest N78fee4fbe96f4bacad948b8ef924bb1f
    166 N4a8462ebd01a47ccb7bd93303738f439 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    167 schema:name Female
    168 rdf:type schema:DefinedTerm
    169 N4f2e0582cd0a4623828d955af8374898 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    170 schema:name Glioma
    171 rdf:type schema:DefinedTerm
    172 N5771bbeaa7ad42779934b3bdbfe1c407 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    173 schema:name Genetic Therapy
    174 rdf:type schema:DefinedTerm
    175 N57923accccbb4bd08bcae279522e7d15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    176 schema:name Flow Cytometry
    177 rdf:type schema:DefinedTerm
    178 N5ced7d01b80f41caafb30b9f6e786514 schema:name dimensions_id
    179 schema:value pub.1048858643
    180 rdf:type schema:PropertyValue
    181 N5d35babb4c4845cd8a14c58b748c9d40 rdf:first sg:person.014171430277.88
    182 rdf:rest N398127fd832d4d2fa49f5f0b2cd0e90a
    183 N60948e3cdf6d424389e0cdbe91052544 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    184 schema:name Cytosine Deaminase
    185 rdf:type schema:DefinedTerm
    186 N65a1d4292984480f9737d8b4c67238a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    187 schema:name Mice, Nude
    188 rdf:type schema:DefinedTerm
    189 N6b7e8ce5406f4b2097c09cf3075ec5ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    190 schema:name Cell Line, Tumor
    191 rdf:type schema:DefinedTerm
    192 N71fe8e7d5355404e8a27e5869d74f774 rdf:first sg:person.01137705050.57
    193 rdf:rest rdf:nil
    194 N720f9e44e8a74d0f831b04338cb7e857 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    195 schema:name Analysis of Variance
    196 rdf:type schema:DefinedTerm
    197 N78fee4fbe96f4bacad948b8ef924bb1f rdf:first sg:person.01042766474.08
    198 rdf:rest N9d1dd7e5e91a459a8541f50e95f8b9cb
    199 N7bcd38b0d57843959711941d741c9444 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    200 schema:name Mice
    201 rdf:type schema:DefinedTerm
    202 N9cd02f0b795248df86325657a9e3d445 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    203 schema:name Pancreatic Neoplasms
    204 rdf:type schema:DefinedTerm
    205 N9d1dd7e5e91a459a8541f50e95f8b9cb rdf:first sg:person.01051663455.47
    206 rdf:rest N0b1c51784688480f99364fd087604772
    207 Nab36a794517d4d62a1e0179dcacffacd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    208 schema:name Immunotherapy
    209 rdf:type schema:DefinedTerm
    210 Nacdd708e8012432fb568486d8acece81 schema:issueNumber 2
    211 rdf:type schema:PublicationIssue
    212 Nafdbfbb9f11940c2b45ddddb57f2889c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    213 schema:name Microscopy, Fluorescence
    214 rdf:type schema:DefinedTerm
    215 Nb87520f3735849018a3fc977d533a849 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    216 schema:name Antibodies, Monoclonal
    217 rdf:type schema:DefinedTerm
    218 Nc69b18a49502479193360b5bc3b47840 schema:name doi
    219 schema:value 10.1038/sj.cgt.7700874
    220 rdf:type schema:PropertyValue
    221 Nd300d20f10d2401cb7dbb94b0b1b0b8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    222 schema:name Animals
    223 rdf:type schema:DefinedTerm
    224 Ne1b725aa86a447dba98e8f7e2d5b3731 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    225 schema:name Blotting, Western
    226 rdf:type schema:DefinedTerm
    227 Ne7159184d4ac4df4b2995a6a40a08539 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    228 schema:name Pentosyltransferases
    229 rdf:type schema:DefinedTerm
    230 Ne96165955aec4624b850375a0209d5ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    231 schema:name Cytotoxicity Tests, Immunologic
    232 rdf:type schema:DefinedTerm
    233 Nf250e7f636524938a49bfc8f35e1cf07 schema:volumeNumber 13
    234 rdf:type schema:PublicationVolume
    235 Nf3f92fb86ecf400a9522488588b5855a schema:name Springer Nature - SN SciGraph project
    236 rdf:type schema:Organization
    237 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    238 schema:name Medical and Health Sciences
    239 rdf:type schema:DefinedTerm
    240 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    241 schema:name Oncology and Carcinogenesis
    242 rdf:type schema:DefinedTerm
    243 sg:grant.2440190 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.cgt.7700874
    244 rdf:type schema:MonetaryGrant
    245 sg:journal.1112008 schema:issn 0929-1903
    246 1476-5500
    247 schema:name Cancer Gene Therapy
    248 schema:publisher Springer Nature
    249 rdf:type schema:Periodical
    250 sg:person.01042766474.08 schema:affiliation grid-institutes:grid.265892.2
    251 schema:familyName Chiz
    252 schema:givenName S
    253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042766474.08
    254 rdf:type schema:Person
    255 sg:person.01051663455.47 schema:affiliation grid-institutes:grid.265892.2
    256 schema:familyName Kaliberova
    257 schema:givenName L N
    258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051663455.47
    259 rdf:type schema:Person
    260 sg:person.01137705050.57 schema:affiliation grid-institutes:grid.265892.2
    261 schema:familyName Buchsbaum
    262 schema:givenName D J
    263 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137705050.57
    264 rdf:type schema:Person
    265 sg:person.01206020250.68 schema:affiliation grid-institutes:grid.265892.2
    266 schema:familyName Kaliberov
    267 schema:givenName S A
    268 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206020250.68
    269 rdf:type schema:Person
    270 sg:person.01302340455.26 schema:affiliation grid-institutes:grid.265892.2
    271 schema:familyName Krendelchtchikova
    272 schema:givenName V
    273 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302340455.26
    274 rdf:type schema:Person
    275 sg:person.014171430277.88 schema:affiliation grid-institutes:grid.265892.2
    276 schema:familyName Della Manna
    277 schema:givenName D
    278 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014171430277.88
    279 rdf:type schema:Person
    280 sg:person.0664616100.38 schema:affiliation grid-institutes:grid.265892.2
    281 schema:familyName Zhou
    282 schema:givenName T
    283 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664616100.38
    284 rdf:type schema:Person
    285 sg:pub.10.1007/s00268-002-4053-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001468017
    286 https://doi.org/10.1007/s00268-002-4053-5
    287 rdf:type schema:CreativeWork
    288 sg:pub.10.1023/b:neon.0000013494.98345.80 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036496053
    289 https://doi.org/10.1023/b:neon.0000013494.98345.80
    290 rdf:type schema:CreativeWork
    291 sg:pub.10.1038/91000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047281881
    292 https://doi.org/10.1038/91000
    293 rdf:type schema:CreativeWork
    294 sg:pub.10.1038/sj.cgt.7700154 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003917459
    295 https://doi.org/10.1038/sj.cgt.7700154
    296 rdf:type schema:CreativeWork
    297 sg:pub.10.1038/sj.cgt.7700189 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007196669
    298 https://doi.org/10.1038/sj.cgt.7700189
    299 rdf:type schema:CreativeWork
    300 sg:pub.10.1038/sj.cgt.7700506 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037799653
    301 https://doi.org/10.1038/sj.cgt.7700506
    302 rdf:type schema:CreativeWork
    303 sg:pub.10.1038/sj.gt.3301196 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019345486
    304 https://doi.org/10.1038/sj.gt.3301196
    305 rdf:type schema:CreativeWork
    306 sg:pub.10.1038/sj.gt.3301557 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036158702
    307 https://doi.org/10.1038/sj.gt.3301557
    308 rdf:type schema:CreativeWork
    309 sg:pub.10.1038/sj.gt.3302215 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013484231
    310 https://doi.org/10.1038/sj.gt.3302215
    311 rdf:type schema:CreativeWork
    312 sg:pub.10.1038/sj.onc.1206290 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047996205
    313 https://doi.org/10.1038/sj.onc.1206290
    314 rdf:type schema:CreativeWork
    315 sg:pub.10.1038/sj.onc.1207971 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033400756
    316 https://doi.org/10.1038/sj.onc.1207971
    317 rdf:type schema:CreativeWork
    318 grid-institutes:grid.265892.2 schema:alternateName Department of Medicine, University of Alabama at Birmingham, 674 Wallace Tumor Institute, Birmingham, Alabama, USA
    319 Department of Radiation Oncology, University of Alabama at Birmingham, 674 Wallace Tumor Institute, Birmingham, Alabama, USA
    320 schema:name Department of Medicine, University of Alabama at Birmingham, 674 Wallace Tumor Institute, Birmingham, Alabama, USA
    321 Department of Radiation Oncology, University of Alabama at Birmingham, 674 Wallace Tumor Institute, Birmingham, Alabama, USA
    322 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...